Cell adhesion down-regulates the expression of vacuolar protein sorting 4B (VPS4B) and contributes to drug resistance in multiple myeloma cells

A Preclinical Assay for Chemosensitivity in Multiple Myeloma

(2013) Z. P. Khin et al.   CANCER RESEARCH

The Expression Changes of Vacuolar Protein Sorting 4B (VPS4B) Following Middle Cerebral Artery Occlusion (MCAO) in Adult Rats Brain Hippocampus

(2013) Gang Cui et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

A role for activator of G-protein signaling 3 (AGS3) in multiple myeloma

(2013) Shan Shao et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Cell adhesion to fibronectin down-regulates the expression of Spy1 and contributes to drug resistance in multiple myeloma cells

(2013) Min Fei et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Evidence of a role for CD44 and cell adhesion in mediating resistance to lenalidomide in multiple myeloma: therapeutic implications

(2013) C C Bjorklund et al.   LEUKEMIA

The role of the orphan G protein-coupled receptor 37 (GPR37) in multiple myeloma cells

(2013) Xianting Huang et al.   LEUKEMIA RESEARCH

Vacuolar protein sorting 4B, an ATPase protein positively regulates the progression of NSCLC via promoting cell division

(2013) Yifei Liu et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Targeting Proliferating Cell Nuclear Antigen and Its Protein Interactions Induces Apoptosis in Multiple Myeloma Cells

(2013) Rebekka Müller et al.   PLoS One

ESCRT-III Assembly and Cytokinetic Abscission Are Induced by Tension Release in the Intercellular Bridge

(2013) J. Lafaurie-Janvore et al.   SCIENCE

Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells

(2013) J. Kronke et al.   SCIENCE

Stimulation of Toll-like receptor-1/2 combined with Velcade increases cytotoxicity to human multiple myeloma cells

(2013) J Abdi et al.   Blood Cancer Journal

Annexin II interactions with the annexin II receptor enhance multiple myeloma cell adhesion and growth in the bone marrow microenvironment

(2012) S. D'Souza et al.   BLOOD

Targeting NAD+ salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition

(2012) M. Cea et al.   BLOOD

Targeting of Adhesion Molecules as a Therapeutic Strategy in Multiple Myeloma

(2012) Paola Neri et al.   CURRENT CANCER DRUG TARGETS

PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma

(2012) Y Zheng et al.   LEUKEMIA

Identification of an AAA ATPase VPS4B-Dependent Pathway That Modulates Epidermal Growth Factor Receptor Abundance and Signaling during Hypoxia

(2012) H. H. Lin et al.   MOLECULAR AND CELLULAR BIOLOGY

ESCRT-III Governs the Aurora B-Mediated Abscission Checkpoint Through CHMP4C

(2012) J. G. Carlton et al.   SCIENCE

Rationally engineered nanoparticles target multiple myeloma cells, overcome cell-adhesion-mediated drug resistance and show enhanced efficacy in vivo

(2012) T Kiziltepe et al.   Blood Cancer Journal

Integrin  7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion

(2011) P. Neri et al.   BLOOD

P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment

(2011) A. K. Azab et al.   BLOOD

Acquisition of Resistance toward HYD1 Correlates with a Reduction in Cleaved  4 Integrin Expression and a Compromised CAM-DR Phenotype

(2011) M. F. Emmons et al.   MOLECULAR CANCER THERAPEUTICS

Mutated RAS and constitutively activated Akt delineate distinct oncogenic pathways, which independently contribute to multiple myeloma cell survival

(2010) T. Steinbrunn et al.   BLOOD

Human ESCRT-III and VPS4 proteins are required for centrosome and spindle maintenance

(2010) E. Morita et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy

(2009) A. K. Azab et al.   BLOOD

Clinical challenges associated with bortezomib therapy in multiple myeloma and Waldenströms Macroglobulinemia

(2009) Jacob P. Laubach et al.   LEUKEMIA & LYMPHOMA

Combined functional and molecular analysis of tumor cell signaling defines 2 distinct myeloma subgroups: Akt-dependent and Akt-independent multiple myeloma

(2008) A. Zollinger et al.   BLOOD

Temporal–spatial expressions of p27kip1 and its phosphorylation on Serine-10 after acute spinal cord injury in adult rat: Implications for post-traumatic glial proliferation

(2008) Aiguo Shen et al.   NEUROCHEMISTRY INTERNATIONAL

Bortezomib overcomes cell adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma

(2008) K Hatano et al.   ONCOGENE